Covered recipient · General Payments record
GERALD R WOODARD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,322.54
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.18 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $171.76 | 5 |
| Amgen Inc. | $162.41 | 3 |
| Acerta Pharma LLC | $55.06 | 3 |
| EISAI INC. | $44.19 | 2 |
| Exact Sciences Corporation | $39.12 | 2 |
| Novo Nordisk AS | $37.49 | 2 |
| Abbott Laboratories | $33.94 | 2 |
| Renalytix AI, Inc. | $24.38 | 1 |
| Averitas Pharma Inc. | $15.26 | 1 |
| Astellas Pharma US Inc | $14.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.97 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125209519 | CMS |
| Abbott Laboratories | $16.97 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125209521 | CMS |
| Amgen Inc. | $23.30 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117418748 | CMS |
| Amgen Inc. | $120.83 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111742056 | CMS |
| Amgen Inc. | $18.28 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117418750 | CMS |
| Astellas Pharma US Inc | $14.57 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139315948 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.05 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105748111 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.05 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104338648 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.96 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104407631 | CMS |
| Averitas Pharma Inc. | $15.26 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133451337 | CMS |
| Eisai Inc. | $20.09 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110746838 | CMS |
| Eisai Inc. | $24.10 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110746840 | CMS |
| Exact Sciences Corporation | $18.89 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114953501 | CMS |
| Exact Sciences Corporation | $20.23 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114953505 | CMS |
| Lilly USA, LLC | $25.85 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135000874 | CMS |
| Lilly USA, LLC | $8.07 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134977988 | CMS |
| Lilly USA, LLC | $21.88 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007799 | CMS |
| Lilly USA, LLC | $19.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135001058 | CMS |
| Lilly USA, LLC | $96.67 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007995 | CMS |
| Novo Nordisk Inc | $18.71 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097153722 | CMS |
| Novo Nordisk Inc | $18.78 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096613946 | CMS |
| Renalytix AI, Inc. | $24.38 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116760314 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.